
|Podcasts|August 15, 2022
Pharmacy Focus: Oncology Edition - An Update on Prostate Cancer and the Growing Role of Pharmacists
As treatments improve and prostate cancer potentially becomes more of a chronic illness, pharmacists have a chance to shine.
Advertisement
This month, we spoke with Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA, director of pharmacy cancer care services at Mayo Clinic, to learn about the latest updates and pipeline treatments in prostate cancer. As treatments improve and prostate cancer potentially becomes more of a chronic illness, Soefje said pharmacists have a chance to shine.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Lerodalcibep for Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia
2
Once-Weekly Retatrutide Reduces Weight and Knee Pain in Patients With Obesity and Osteoarthritis
3
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
4
FDA Approves T-DXd With Pertuzumab for First-Line Treatment of Advanced HER2+Breast Cancer
5

















































































































































































































